Published in Hered Cancer Clin Pract on November 15, 2004
Multiple osteochondromas. Orphanet J Rare Dis (2008) 2.61
Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab (2012) 1.15
Osteochondroma of bilateral mandibular condyle: a case report. Int J Clin Exp Med (2015) 0.88
Malignant progression in two children with multiple osteochondromas. Sarcoma (2010) 0.86
Exome sequencing and functional analysis identifies a novel mutation in EXT1 gene that causes multiple osteochondromas. PLoS One (2013) 0.82
A broad spectrum of genomic changes in latinamerican patients with EXT1/EXT2-CDG. Sci Rep (2014) 0.81
Detection of exostosin glycosyltransferase gene mutations in patients with non-hereditary osteochondromas of the mandibular condyle. Mol Clin Oncol (2016) 0.78
A mountain among molehills: removing an impinging large femoral neck osteochondroma in a man with hereditary multiple exostoses. BMJ Case Rep (2014) 0.78
Spinal exostosis in a boy with multiple hereditary exostoses. Case Rep Orthop (2013) 0.77
Multiple heriditary exostoses in a family for three generation of Indian origin with review of literature. J Clin Diagn Res (2014) 0.75
Bilateral Scapulothoracic Osteochondromas in a Patient With Hereditary Multiple Exostosis: A Case Report and Review of the Literature. Orthop Rev (Pavia) (2016) 0.75
Case Report of the positive exostosin-1 without B-cell lymphoma-2 gene expression of giant cell tumor lesion in hereditary multiple exostosis. Int J Surg Case Rep (2016) 0.75
Daughter and mother diagnosed with hereditary multiple exostoses: A case report and a review of the literature. Medicine (Baltimore) (2017) 0.75
Ankle pain in hereditary multiple exostoses: a case report. Rheumatol Int (2014) 0.75
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat (2003) 12.88
CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol (2003) 9.13
Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87
Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis (1989) 5.88
Molecular diversity of heparan sulfate. J Clin Invest (2001) 5.40
Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer (1977) 4.07
The natural history of hereditary multiple exostoses. J Bone Joint Surg Am (1994) 3.88
Toward a molecular understanding of skeletal development. Cell (1995) 3.55
Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature (1998) 3.34
Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev (2002) 2.75
Dysplasia epiphysialis hemimelica (tarso-ephiphysial aclasis). J Bone Joint Surg Br (1956) 2.63
The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem (1998) 2.47
Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development (1998) 2.40
Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol (2003) 2.36
The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci U S A (2000) 2.30
Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet (1995) 2.29
Cartilage proteoglycans. Semin Cell Dev Biol (2001) 2.17
Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol (2000) 2.14
Natural history study of hereditary multiple exostoses. Am J Med Genet (1995) 2.09
Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Dev Cell (2004) 2.06
Distinct and collaborative roles of Drosophila EXT family proteins in morphogen signalling and gradient formation. Development (2004) 2.01
A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet (1994) 2.00
Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat (2004) 1.94
FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev (1999) 1.94
Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics (1998) 1.90
Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol (1997) 1.87
The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet (1996) 1.87
Hedgehog movement is regulated through tout velu-dependent synthesis of a heparan sulfate proteoglycan. Mol Cell (1999) 1.84
Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways. Development (2004) 1.80
Genetic heterogeneity in families with hereditary multiple exostoses. Am J Hum Genet (1993) 1.77
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70
Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet (1994) 1.68
Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev (1996) 1.66
Hereditary multiple exostoses. Anthropometric, roentgenographic, and clinical aspects. J Bone Joint Surg Am (1979) 1.65
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest (2000) 1.62
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem (1999) 1.58
Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet (1996) 1.58
Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet (1997) 1.49
Malignant transformation of a multiple cartilaginous exostosis--a case report. Int Orthop (1997) 1.49
Cerebellar proteoglycans regulate sonic hedgehog responses during development. Development (2002) 1.45
The syndecans, tuners of transmembrane signaling. FASEB J (1999) 1.40
Genotype-phenotype correlation in hereditary multiple exostoses. J Med Genet (2001) 1.40
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet (1998) 1.39
Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer (1999) 1.37
Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. Am J Hum Genet (1997) 1.34
Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res (1997) 1.31
Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology (2000) 1.28
Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem (1998) 1.27
Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis. Proc Natl Acad Sci U S A (2001) 1.26
[Metachondromatosis]. Z Kinderheilkd (1971) 1.26
Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics (1998) 1.24
Heparan sulfate proteoglycan modulation of developmental signaling in Drosophila. Biochim Biophys Acta (2002) 1.23
Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions in the short arm of chromosome 11. Am J Hum Genet (1996) 1.23
Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J Cell Sci (1995) 1.21
Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J Bone Miner Res (2000) 1.17
Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur J Hum Genet (1998) 1.17
Langer-Giedion syndrome. Birth Defects Orig Artic Ser (1974) 1.17
Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development (1993) 1.16
Genomic organization and promoter structure of the human EXT1 gene. Genomics (1997) 1.15
Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses. Am J Hum Genet (1997) 1.15
Hereditary multiple exostoses and heparan sulfate polymerization. Biochim Biophys Acta (2002) 1.15
Loss of chromosome band 8q24 in sporadic osteocartilaginous exostoses. Genes Chromosomes Cancer (1994) 1.13
Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J Biol Chem (1999) 1.12
Interstitial deletion of 11(p11.2p12): a newly described contiguous gene deletion syndrome involving the gene for hereditary multiple exostoses (EXT2). Am J Med Genet (1996) 1.10
EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev Dyn (2000) 1.08
Metachondromatosis. Report of four cases. J Bone Joint Surg Am (1985) 1.07
Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses. Hum Mutat (1998) 1.07
Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology (1993) 1.06
Refinement of the multiple exostoses locus (EXT2) to a 3-cM interval on chromosome 11. Am J Hum Genet (1995) 1.05
Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol (2000) 1.05
Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem (1990) 1.03
The structure of the human multiple exostoses 2 gene and characterization of homologs in mouse and Caenorhabditis elegans. Genome Res (1997) 1.03
Heparan sulfate abnormalities in exostosis growth plates. Bone (2002) 1.00
Mutation analysis of hereditary multiple exostoses in the Chinese. Hum Genet (1999) 1.00
Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses. J Clin Pathol (2002) 1.00
Clinical correlation to genetic variations of hereditary multiple exostosis. J Pediatr Orthop (1999) 0.98
Embryonic fibroblasts with a gene trap mutation in Ext1 produce short heparan sulfate chains. J Biol Chem (2004) 0.96
Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol (2001) 0.96
Indian hedgehog and syndecans-3 coregulate chondrocyte proliferation and function during chick limb skeletogenesis. Dev Dyn (2004) 0.96
Molecular definition of the shortest region of deletion overlap in the Langer-Giedion syndrome. Am J Hum Genet (1991) 0.94
An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet (1997) 0.94
Reduction of basic fibroblasts growth factor receptor is coupled with terminal differentiation of chondrocytes. J Biol Chem (1991) 0.92
New perspectives on the molecular basis of hereditary bone tumours. Mol Med Today (1999) 0.91
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors. Int J Cancer (1993) 0.90
Spindle-cell sarcoma in patients who have osteochondromatosis. A report of two cases. J Bone Joint Surg Am (1988) 0.88
Osteosarcoma arising from a multiple exostoses lesion: case report. Jpn J Clin Oncol (1990) 0.87
Osteosarcoma arising in a solitary osteochondroma of the fibula. Arch Pathol Lab Med (1999) 0.87
EXTL3/EXTR1 alterations in colorectal cancer cell lines. Int J Oncol (1999) 0.86
Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses. J Hum Genet (1999) 0.85
Isolation and characterization of the murine homolog of the human EXT2 multiple exostoses gene. Biochem Mol Med (1997) 0.83
Flow cytometric analysis of DNA in bone and soft-tissue tumors using nuclear suspensions. Cancer (1987) 0.82
Mutation screening of the EXT genes in patients with hereditary multiple exostoses in Taiwan. Genet Test (2002) 0.82
Isolation of the mouse cDNA homologous to the human EXT1 gene responsible for Hereditary Multiple Exostoses. DNA Seq (1997) 0.82
Inhibition of in vitro limb cartilage differentiation by syndecan-3 antibodies. Dev Dyn (1996) 0.81
Flow cytometric determination of DNA content in malignant and benign bone tumours. Cytometry (1985) 0.79
The murine Ext1 gene shows a high level of sequence similarity with its human homologue and is part of a conserved linkage group on chromosome 15. Cytogenet Cell Genet (1997) 0.77
Hereditary multiple exostoses. Report of a family. Clin Orthop Relat Res (1984) 0.76
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol (2011) 5.73
Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum (2003) 1.92
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol (2010) 1.91
MRI assessment of knee osteoarthritis: Knee Osteoarthritis Scoring System (KOSS)--inter-observer and intra-observer reproducibility of a compartment-based scoring system. Skeletal Radiol (2004) 1.76
Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol (2010) 1.67
Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array. Epigenetics Chromatin (2013) 1.62
Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet (2008) 1.60
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression. J Pathol (2010) 1.22
Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin. Hum Pathol (2005) 1.15
MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma. Orphanet J Rare Dis (2013) 1.13
Patients with severe radiographic osteoarthritis have a better prognosis in physical functioning after hip and knee replacement: a cohort-study. PLoS One (2013) 1.11
Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. Arthritis Rheum (2004) 1.10
Distinct histological features characterize primary angiosarcoma of bone. Histopathology (2011) 1.10
The clinical use of biomarkers as prognostic factors in Ewing sarcoma. Clin Sarcoma Res (2012) 1.00
A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient. Lab Invest (2004) 1.00
Thumb base involvement in symptomatic hand osteoarthritis is associated with more pain and functional disability. Ann Rheum Dis (2010) 0.98
Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch (2012) 0.95
A short-term in vivo model for giant cell tumor of bone. BMC Cancer (2011) 0.92
Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes. Mod Pathol (2009) 0.91
A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone. Am J Surg Pathol (2010) 0.91
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis. Clin Sarcoma Res (2012) 0.91
Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration "PALGA". J Pediatr Orthop (2007) 0.90
Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial. Radiother Oncol (2003) 0.90
Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples. BMC Res Notes (2011) 0.89
Vascular tumors of bone: imaging findings. Eur J Radiol (2010) 0.89
The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease. Clin Sarcoma Res (2012) 0.88
Association of the risk of osteoarthritis with high innate production of interleukin-1beta and low innate production of interleukin-10 ex vivo, upon lipopolysaccharide stimulation. Arthritis Rheum (2005) 0.87
Using the common sense model of illness perceptions to examine osteoarthritis change: a 6-year longitudinal study. Health Psychol (2010) 0.85
Association between several clinical and radiological determinants with long-term clinical progression and good prognosis of lower limb osteoarthritis. PLoS One (2011) 0.83
Long-term follow-up of a high-intensity exercise program in patients with rheumatoid arthritis. Clin Rheumatol (2009) 0.83
A ΔRaf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures. J Pathol (2011) 0.82
Interobserver reliability in the histopathological diagnosis of cartilaginous tumors in patients with multiple osteochondromas. Mod Pathol (2012) 0.82
Osteosarcoma of the femur with skip, lymph node, and lung metastases. Radiographics (2008) 0.80
Paget's disease of bone in The Netherlands: a population-based radiological and biochemical survey--the Rotterdam Study. J Bone Miner Res (2004) 0.78
Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis. J Rheumatol (2013) 0.77
Results of diagnostic review in pediatric bone tumors and tumorlike lesions. J Pediatr Orthop (2008) 0.76
No association between BMD and prevalent vertebral fractures in liver transplant recipients at time of screening before transplantation. J Clin Endocrinol Metab (2014) 0.76
An innovative care model coordinated by a physical therapist and nurse practitioner for osteoarthritis of the hip and knee in specialist care: a prospective study. Rheumatol Int (2013) 0.76
Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis. Arthritis Rheum (2005) 0.76
Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours. Clin Sarcoma Res (2012) 0.75
Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features. Clin Sarcoma Res (2011) 0.75
Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH. Clin Sarcoma Res (2012) 0.75
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol (2016) 0.75
Familial influence on tibiofemoral alignment. Ann Rheum Dis (2009) 0.75
Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatment. J Bone Miner Res (2014) 0.75
Hyperplasia of rib and vertebra, associated with infiltrating lipoma: a rare case of focal overgrowth. Eur Spine J (2014) 0.75
Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints. Rheumatology (Oxford) (2012) 0.75
[A man with progressive neck and shoulder pain]. Ned Tijdschr Geneeskd (2012) 0.75
The Journal of Pathology 2008 Jeremy Jass Prize for Research Excellence in Pathology. J Pathol (2009) 0.75